Eyeonics Files For IPO

It seems most likely that the reason that the major ophthalmic houses did not want the Crystalens-Eyeonics company is that the technology has substantial problems.  Unlike the multifocal lenses, in order to give the best possible distance vision, near vision is not adequate to read ordinary small print.  Some surgeons complain of large numbers of long-term surgical...

Rather than getting gobbled up by one of the big three players in Ophthalmology (B & L, Alcon and AMO), eyeonics is looking to go it alone into the public arena.  The crystalens remains the only approved accommodative intraocular lens, but faces strong competition from the multifocals.  Although it is generally agreed that quality of vision is better with the crystalens because the multifocals...